Gene transfer and epithelial cell transplantation technologies play an important role in the development of new therapeutic concepts for liver diseases. Although liver organ transplantation has revolutionized the treatment of a wide spectrum of acute and chronic liver diseases, gene- and cell-based therapies are emerging at an astonishing pace, because they promise to be less invasive, less costly and at least as effective as currently established therapy protocols. Experimental gene therapy models have been developed for a wide spectrum of liver diseases, including hereditary liver disorders, malignant liver disease and viral hepatitis. Hepatocyte transplantation (HcTx) is being explored as treatment of severe chronic and acute liver failure as well as for hereditary liver diseases. Most of these procedures and techniques are still experimental or have been applied to a small number of patients only. Rigorous clinical evaluation will finally demonstrate the usefulness of each new procedure in the daily clinical care of patients with liver disease. In this review, we have attempted to provide an introduction and survey of the topics of gene therapy and HcTx with specific examples of laboratory and clinical achievements highlighting potential applications in liver diseases.

Keywords:
Hepatocyte, Transplantation, Liver, Gene therapy
1.
Adams, R.M., H.E. Soriano, M. Wang, G. Darlington, D. Steffen, F.D. Ledley (1992) Transduction of primary human hepatocytes with amphotropic and xenotropic retroviral vectors. Proc Natl Acad Sci USA 89: 8981–8985.
2.
Bilheimer, D.W., J.L. Goldstein, S.M. Grundy, T.E. Starzl, M.S. Brown (1984) Liver transplantation to provide low-density lipoprotein receptors and lower plasma cholesterol in a child with homozygous familial hypercholesterolemia. N Engl J Med 311: 1658–1664.
3.
Bilir, B.M., D. Guenette, A. Ostrowska, J. Durham, D. Kumpe, J. Krysl, R. Shresta, T. Trouillot, I. Teitelbaum, G.T. Everson (1997) Percutaneous hepatocyte transplantation (PHT) in liver failure. Gastroenterology 26: A494.
4.
Bilir, B.M., D. Kumpe, J. Krysl, D. Guenette, A. Ostrowska, G.T. Everson, R. Shresta, T.C. Lin, W. Cole, J. Lear, J. Durham (1998) Hepatocyte transplantation (HT) in patients with liver cirrhosis. Gastroenterology 11: L0056.
5.
Boyce, F.M., N.L.R. Bucher (1996) Baculovirus-mediated gene transfer into mammalian cells. Proc Natl Acad Sci USA 93: 2348–2352.
6.
Chang, C., D.E. Ganem, J.E. Lavine (1991) Foreign gene delivery and expression in hepatocytes using hepatitis B virus vector. Hepatology 14: 124A.
7.
Dabeva, M., E. Hurston, D.A. Shafritz (1995) Transcription factor and liver specific mRNA expression in facultative epithelial progenitor cells of liver and pancreas. Am J Pathol 147: 1633–1648.
8.
Das, S., M. Ott, A. Yamane, W. Tsai, M. Gromeier, F. Lahser, S. Gupta, A. Dasgupta (1998) A small yeast RNA blocks hepatitis C virus internal ribosome entry site (HCV IRES)-mediated translation and inhibits replication of a chimeric poliovirus under translational control of the HCV IRES element. J Virol 72: 5638–5647.
9.
Demetriou, A.A., J.F. Whiting, D. Feldman, S.M. Levenson, N. Roy Chowdhury, A.D. Moscioni, M. Kram, J. Roy Chowdhury (1986) Replacement of liver function in rat by transplantation of microcarrier-attached hepatocytes. Science 233: 1190–1192.
10.
Dixit, V., R. Darvasi, M. Arthur, M. Brezina, K. Lewin, G. Gitnik (1990) Restoration of liver function in Gunn rats without immunosuppression using transplanted microencapsulated hepatocytes. Hepatology 12: 1342–1349.
11.
Ferry, N., O. Duplessis, D. Houssin, O. Danos, J. Heard (1991) Retroviral mediated gene transfer into hepatocytes in vivo. Proc Natl Acad Sci USA 88: 8377–8381.
12.
Flotte, T.R., B.J. Carter (1995) Adeno-associated virus vectors for gene therapy. Gene Ther 2: 357–362.
13.
Fox, I.J., N.R. Chowdhury, J.R. Chowdhury (1997) Hepatocyte transplantation in liver failure and inherited metabolic disorders; in Lee, W.M., R. Williams (eds): Acute Liver Failure pp 285–301.
14.
Fox, I.J., J. Roy Chowdhury, S.S. Kaufman, T.C. Goertzen, N. Roy Chowdhury, P.I. Warkentin, K. Dorko, B.V. Sauter, S.C. Strom (1998) Treatment of Crigler-Najjar syndrome type I with hepatocyte transplantation. N Engl J Med 338: 1422–1426.
15.
Gagandeep, S., M. Ott, R.P. Sokhi, S. Gupta (1997) Loss of adenovirally transduced cells rather than transgene extinction is rate limiting in adenoviral hepatic gene transfer. Gastroenterology 122: A1269.
16.
Geissler, M., K. Tokushige, C.C. Chante, V.R. Zurawski, J. Wands (1997) Cellular and humoral immune response to hepatitis B virus structural proteins in mice after DNA-based immunization. Gastroenterology 112: 1307–1320.
17.
Goldstein, J.L., H.H. Hobbs, M.B. Brown (1995) Familial hypercholesterolemia; in Scriver, C.R., A.L. Beaudet, W.S. Sly, D. Valle (eds): The Metabolic and Molecular Bases of Inherited Disease. New York, McGraw-Hill, pp 1981–2030.
18.
Grossman, M., D.J. Rader, D.W.M. Muller, et al. (1995) A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia. Nat Med 1: 1148–1154.
19.
Gundlach, B.R., H. Linhart, U. Dittmer, S. Sopper, S. Reiprich, D. Fuchs, B. Fleckenstein, G. Hunsmann, C. Stahl-Hennig, K. Uberla (1997) Construction, replication, and immunogenic properties of a simian immunodeficiency virus expressing interleukin 2. J Virol 71: 2225–2232.
20.
Gupta, S., P. Rajvanshi, K.K. Bhargava, A. Kerr (1996) Hepatocyte transplantation: Progress toward liver repopulation. Prog Liver Dis 14: 199–222.
21.
Gupta, S., P. Rajvanshi, C.D. Lee (1995) Integration of transplanted hepatocytes in host liver plates demonstrated with dipeptidyl peptidase IV deficient rats. Proc Natl Acad Sci USA 92: 5860–5864.
22.
Gupta, S., R.P. Vemuru, C.D. Lee, P. Yerneni, E. Aragona, R.D. Burk (1994) Hepatocytes exhibit superior transgene expression after transplantation into liver and spleen compared with the peritoneal cavity or dorsal fat pad: Implications for hepatic gene therapy. Hum Gene Ther 5: 959–967.
23.
Gupta, S., P., Yerneni, R.P. Vemuru, C.D. Lee, E.L. Yellin, K.K. Bhargava (1993) Studies on the safety of intrasplenic hepatocyte transplantation: Relevance to ex-vivo gene therapy and liver repopulation in acute hepatic failure. Hum Gene Ther 4: 249–257.
24.
Habibullah, C.M., I.H. Syed, A. Qamar, Z. Taher-Uz (1994) Human fetal hepatocyte transplantation in patients with fulminant hepatic failure. Transplantation 58: 951–952.
25.
Hoeg, J.M., T.E. Starzl, H.B. Brewer (1987) Liver transplantation for the treatment of cardiovascular disease: Comparison with medication and plasma exchange in homozygous familial hypercholesterolaemia. Am J Cardiol 59: 705–707.
26.
Huber, B.E., C.A. Richards, T.A. Krenitsky (1991) Retroviral-mediated gene therapy for the treatment of hepatocellular carcinoma: An innovative approach for cancer therapy. Proc Natl Acad Sci USA 88: 8039–8043.
27.
Hwu P., J. Yannelli, M. Kriegler, et al. (1993) Functional and molecular characterisation of tumor-infiltrating lymphocytes transduced with tumor necrosis factor-alpha cDNA for the gene therapy of cancer in humans. J Immunol 150: 4104–4115.
28.
Ilan, Y., B. Sauter, N. Roy Chowdhury, G. Droguett, B.V.N. Reddy, A. Davidson, M.S. Horwitz, J. Roy Chowdhury (1997) Expression of adenoviral E3 gene products in normal rat hepatocytes prevents rejection upon transplantation into allogeneic Gunn rats. Gastroenterology 26: A490.
29.
Ilan, Y., B. Sauter, N.R. Chowdhury, B.V. Reddy, N.R. Thummala, G. Droguett, A. Davidson, M. Ott, M.S. Horwitz, J.R. Chowdhury (1998) Oral tolerization to adenoviral proteins permits repeated adenovirus-mediated gene therapy in rats with pre-existing immunity to adenoviruses. Hepatology 27: 1368–1376.
30.
Jaffe, J.A., C. Daniel, M. Longenecker (1992) Adenovirus mediated in vivo gene transfer and expression in normal rat liver. Nat Genet 1: 372–378.
31.
Kren, B.T., P. Bandyopadhyay, J.R. Chowdhury, C.J. Steer (1998a) Site directed mutagenesis of genomic DNA in isolated rat hepatocytes and intact liver mediated by chimeric RNA/DNA complexes. Hepatology 26(suppl): 250A.
32.
Kren, B.T., P. Bandyopadhyay, C.J. Steer (1998b) In vivo site directed mutagenesis of the factor IX gene by chimeric RNA/DNA oligonucleotides. Nat Med 4: 285–290.
33.
Kusano, M., M. Mito (1982) Observation on the fine structure of long survived isolated hepatocytes inoculated into rat spleen. Gastroenterology 82: 616–628.
34.
Lebkowski, J.S., M.M. McNally, T.B. Okarma, L.B. Lerch (1988) Adeno-associated virus: A vector system for efficient introduction and integration of DNA into a variety of mammalian cell types. Mol Cell Biol 8: 3988–3996.
35.
Ledley, F.D. (1995) Non-viral gene therapy: The promise of genes as pharmaceutical products. Hum Gene Ther 6: 1129–1144.
36.
Li, Q.T., M.A. Kay, M. Finegold, L.D. Stratford-Perricaudet, S.L.C. Woo (1993) Assessment of recombinant adenoviral vectors for hepatic gene therapy. Hum Gene Ther 4: 403–409.
37.
Lusky, M., M. Christ, K. Rittner, A. Dieterle, D. Dreyer, B. Mourot, H. Schultz, F. Stoeckel, A. Pavirani, M. Mehtali (1998) In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1/E2A or E1/E4 deleted. J Virol 72: 2022–2032.
38.
Maganto, P., P.G. Traber, C. Rusnell, W.O. Dobbins III, D. Keren, J.J. Gumucio (1990) Long-term maintenance of the adult pattern of liver-specific expression for P-450b, P-450e, albumin and α-fetoprotein genes in intrasplenically transplanted hepatocytes Hepatology 11: 585–592.
39.
Miyake, K., N. Suzuki, H. Matsuoka, T. Tohyama, T. Shimada (1998) Stable integration of human immunodeficiency virus based retrovirus vectors into the chromosomes of nondividing cells. Hum Gene Ther 9: 467–475.
40.
Miyanohara, A., P.A. Johnson, R.L. Elam, Y. Dai, J.L. Witztum, I.M. Verma, T. Friedmann (1992) Direct gene transfer to the liver with herpes simplex type 1 vectors: Transient production of physiologically relevant levels of circulating factor IX. New Biol 4: 238–246.
41.
Mulligan, R.C. (1993) The basic science of gene therapy. Science 260: 926–932.
42.
Naldini, L., U. Blomer, P. Gallay, D. Ory, R. Mulligan, F.H. Gage, I.M. Verma, D. Trono (1996) In vivo gene delivery and stable transduction of nondividing cells cells by a lentivirus vector. Science 272: 263–267.
43.
Ott, M., P. Rajvanshi, R.P. Sokhi, G. Alpini, E. Aragona, M. Dabeva, D.A. Shafritz, S. Gupta (1998) Differentiation-specific regulation of transgene expression in a diploid epithelial cell line derived from the normal F344 rat liver. Submitted.
44.
Ott, M., R.J. Stockert, S. Gagandeep, S. Gupta (1998) Simultaneous upregulation of viral receptor expression and DNA synthesis is required for increasing efficiency of retroviral hepatic gene transfer. J Biol Chem 273: 11954–11961.
45.
Pardoll, D.M. (1993) Cancer vaccines. Immunol Today 14: 310–316.
46.
Peng, H., D. Armstrong, L. Mackenzie-Graham, et al. (1988) Retroviral-mediated gene transfer and expression of human phenylalanine hydroxylase in primary mouse hepatocytes. Proc Natl Acad Sci USA 85: 8146–8150.
47.
Petersen, J., M. Ott, C.E. Rogler, S. Gupta, L.E. Rogler (1997) An embryonic hepatoblast cell line differentiates bipotentially in vitro and in vivo. Cold Spring Harbour Meeting, Cold Spring Harbour, Cold Spring Harbour Press, p 7.
48.
Rajvanshi, P., A. Kerr, S. Gupta (1995) Repeated hepatocyte transplantation for massive liver repopulation is safe and effective. Gastroenterology 108: A1153.
49.
Rogler, L.E. (1997) Selective bipotential differentiation of mouse embryonic hepatoblasts in vitro. Am J Pathol 150: 591–602.
50.
Roy Chowdhury, J., M. Grossman, S. Gupta, N. Roy Chowdhury, J.M. Wilson (1991) Long-term improvement of hypercholesterolemia after ex vivo gene therapy in LDL receptor deficient rabbits. Science 254: 1802–1805.
51.
Shoji, I., H. Aizaki, H. Tani, K. Ishii, T. Chiba, I. Saito, T. Miyamura, Y. Matsuura (1997) Efficient gene transfer into various cells, including nonhepatic cells, by baculovirus vectors. J Gen Virol 78: 2657–2664.
52.
Sigal, S.H., S. Brill, A.S. Fiorino, L.M. Reid (1992) The liver as the stem cell and lineage system. Am J Physiol 263: G139–G148.
53.
Soriano, H.E., R.P. Wood, D.C. Kang, C.F. Ozaki, M.J. Finegold, F. Bischoff, B.S. Reid, G.D. Ferry (1997) Hepatocellular transplantation (HCT) in children with fulminant liver failure (FLF). Gastroenterology 26: A443.
54.
Stratford-Perricaudet, L.D., M. Levrero, J.F. Chasse, M. Perricaudet, P. Briand (1990) Evaluation of the transfer and expression in mice of an enzyme-encoding gene using a human adenovirus vector. Hum Gene Ther 1: 241–256.
55.
Strauss, M. (1994) Liver directed gene therapy: Prospects and problems. Gene Ther 1: 156–164.
56.
Vile, R., S.J. Russell (1994) Gene transfer technologies for the gene therapy of cancer. Gene Ther 1: 88–98.
57.
von Weizäcker, F., S. Wieland, J. Kock, W.B. Offensperger, S. Offensperger, D. Moradpour, H.F. Blum (1997) Gene therapy for chronic viral hepatitis: Ribozymes, antisense oligonucleotides and dominant negative mutants. Hepatology 26: 251–255.
58.
Wands, J.R., M. Geissler, J.Z. Putlitz, H. Blum, F.V. Weizacker, L. Mohr, S.K. Yoon, M. Melegari, P.P. Scaglioni (1997) Nucleic acid-based antiviral and gene therapy of chronic hepatitis B infection. J Gastroenterol Hepatol 12: S354–S369.
59.
Wilson, J.M., D.M. Jefferson, J. Roy Chowdhury, P.M. Novikoff, D.M. Johnston, R.C. Mulligan (1988) Retrovirus mediated transduction of adult hepatocytes. Proc Natl Acad Sci USA 85: 3014–3018.
60.
Wilson, J.M., D.E. Johnston, D.M. Jefferson, R.C. Mulligan (1988) Correction of the genetic defect in hepatocytes from the Watanabe heritable hyperlipidemic rabbit. Proc Natl Acad Sci USA 85: 4421–4425.
61.
Wilson, J.M., N. Roy Chowdhury, M. Grossman, et al. (1990) Temporary amelioration of hyperlipidemia in low density lipoprotein receptor-deficient rabbits transplanted with genetically modified hepatocytes. Proc Natl Acad Sci USA 87: 8437–8441.
62.
Wu, G.Y., J.M. Wilson, F. Shalaby, M. Grossmann, D.A. Shafritz, C.H. Wu (1991) Receptor-mediated gene delivery in vivo. Partial correction of genetic analbuminemia in Nagase rats. J Biol Chem 266: 14338–14342.
63.
Wu, C.H., G.Y. Wu (1998) Targeted inhibition of hepatitis C virus-directed gene expression in human hepatoma cell lines. Gastroenterology 114: 1304–1312.
64.
Wu, G.Y., C.H. Wu (1987) Receptor-mediated in vitro gene transformation by a soluble DNA carrier system. J Biol Chem 262: 4429–4432.
65.
Yang, W., H.C.J. Ertl, J.M. Wilson (1994) MHC class I restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity 433: 433–442.
© 2000 S. Karger AG, Basel
2000
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.